Stock fact sheet · data as of

Defiance KSM Israel 120 ETF (ISRL): fair value, margin of safety and Wheel Score

Financial Services · Asset Management · United States · Speculative / Distressed

Close23.74
GLS fair value2.694 of 9 models
Margin of safety-782%price above fair value
Wheel Score3No optionscapped: no options
Health0/9Piotroski F-score
Moat0.0/10GLS 10-year score
Market cap$1M0k shares a day
Implied vol.-no listed options
P/E77.8EPS 0.31
Dividend yieldnone
Beta2.21moves more than the market
Next earnings-no date recorded

Is ISRL undervalued?

At 23.74 (close of 16 Oct 2026), ISRL trades 782% over the GLS average fair value of 2.69, with 0 of 4 models above the price. The stock earns none of the Wheel Score's Value points at this price. That is a statement about price against trailing fundamentals, not about the company's prospects - the Wall Street View and the Growth tab on the Quote page carry the forward numbers.

The 4 models disagree widely: Lynch gives 1.22 while Graham Growth gives 4.92. A spread that wide means the average is sensitive to which methods you trust; the model table below shows where each one lands, and the Quote page lets you switch any of them off.

The nightly engine files ISRL under Speculative / Distressed - negative earnings or a Piotroski score of 3 or less - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.

Nine valuation models for ISRL

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF--Present value of the projected free cash flows, discounted at the cost of capital; no value tonight
Graham Number--The most a defensive investor pays for the earnings and book value per share; no value tonight
Graham Growth4.92-79%Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields
Lynch1.22-95%EPS × the earnings growth rate (PEG of 1), growth capped at 25%
GLS Growth1.23-95%EPS compounded ten years at the blended growth rate, discounted back at 15% a year
10 Cap--Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%; no value tonight
Payback Time--Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight
DDM--Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight
EPV3.39-86%Earnings power value: current EPS capitalised at 9% with no growth
Zombie (liquidation)0.0000-100%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target0.0000-100%Analysts' average 12-month price target. Not in the average

Quality and financial health

Financial health is weak: ISRL passes 0 of the nine Piotroski tests. Our screens drop the stock at the health rule; a low score is often the reason a stock looks cheap on the valuation models. The GLS Moat score is low at 0.0 out of 10, which says the ten-year record of revenue, earnings, margins and returns on capital has been inconsistent - growth and shocks rather than steady compounding.

Returns on capital are thin or negative - ROIC 0.0%, ROE 0.0%, ROA 0.0% - with debt at 0.00 times equity and negative free cash flow.

Defiance KSM Israel 120 ETF pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain.

Institutional ownership scores 10/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score0 / 9ROIC0.0%
GLS Moat0.0 / 10ROE0.0%
Debt / equity0.00ROA0.0%
Free-cash-flow yield-17.4%Payout ratio0%
Institutions10 / 10Insiders · Congress5 · 5 / 10

Wheel Score 3: No options

ISRL has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business; the Wheel Score is capped at 39 and shown as "No options" (3 here). The valuation and quality numbers still apply to owning the shares outright.

Volume runs at 0k shares a day on a market cap of $1M, with a beta of 2.21 - a high beta, so the stock tends to move more than the market and a strike can be gapped through; the Stability part of the Wheel Score gives that 3 of 20.

PartPointsFrom
Value0 / 25-782% margin of safety
Health0 / 20Piotroski 0/9
Moat0 / 15moat 0.0/10
Premium0 / 20no option data
Stability3 / 200k shares/day, $1M cap, beta 2.21

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

No upcoming earnings date is recorded for ISRL in the nightly calendar.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Asset Management

The 12 companies below are the closest to Defiance KSM Israel 120 ETF by market cap within the Asset Management industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
GLBL
Pacer MSCI World Industry Advan
28.7377.36+63%39No options$1M
USMD
CoreValues America First Technology ETF
32.758.12-303%15No options$1M
ATC
GraniteShares Autocallable COIN ETF
24.8110.36-139%0No options$993K
ARCX
Tradr 2X Long ACHR Daily ETF
7.0419.23+63%30Weak$2M
CRY
GraniteShares YieldBOOST CRCL ETF
15.8119.63+19%26No options$874K
GDT
WisdomTree Efficient TIPS Plus Gold Fund
33.8513,992.03+100%31No options$846K
NYNY
Corgi NYC Based ETF
26.7231.67+16%45Weak$802K
LAZR
Tema Photonics & Optical ETF
37.99--33Weak$760K
INT
Corgi ETF Trust I - Corgi INTC 2x Daily ETF
15.31--19No options$733K
GNMX
Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF
37.200.1745-21212%21Weak$2M
BREW
Corgi ETF Trust I - Corgi Coffee & Energy Drinks ETF
26.6310.52-153%30Weak$673K
CIR
Corgi ETF Trust I - Corgi CRCL 2x Daily ETF
32.179.31-246%6No options$644K

⚖ Compare ISRL with 7 of them   All Financial Services stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about ISRL

Is ISRL undervalued right now?

No: at 23.74 the stock trades 782% above the GLS average fair value of 2.69 (data as of 16 Oct 2026), well beyond what trailing earnings, cash flow and book value support.

What is the Wheel Score of ISRL and what does it mean?

ISRL has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".

What is the GLS fair value for ISRL?

2.69 per share as of 16 Oct 2026 - the simple average of the 4 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does Defiance KSM Israel 120 ETF report earnings next?

No upcoming earnings date is recorded for ISRL in our calendar as of 16 Oct 2026; the Calendars page is refreshed every morning.

Does ISRL have listed options, and how liquid are they?

No. The nightly options snapshot found no listed contracts on ISRL, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.